CREBBP and leukemia: In human leukaemia cell lines, it was also demonstrated that the CREBBP/EP300 bromodomain is essential for regulating the GATA1/MYC regulatory axis during proliferation, and administration of CREBBP/EP300 bromodomain inhibitors was very effective in reducing H3K27ac levels and thus hindering cancer cell proliferation [102].